Masao Iwagami

ORCID: 0000-0001-7079-0640
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Medical Coding and Health Information
  • Ocular Surface and Contact Lens
  • Chronic Disease Management Strategies
  • COVID-19 Clinical Research Studies
  • Allergic Rhinitis and Sensitization
  • COVID-19 and healthcare impacts
  • Acute Kidney Injury Research
  • Geriatric Care and Nursing Homes
  • Clinical practice guidelines implementation
  • Sepsis Diagnosis and Treatment
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 and COVID-19 Research
  • Global Health Care Issues
  • Emergency and Acute Care Studies
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiac, Anesthesia and Surgical Outcomes
  • Biomedical Text Mining and Ontologies
  • Dialysis and Renal Disease Management
  • Palliative Care and End-of-Life Issues
  • Climate Change and Health Impacts
  • Respiratory Support and Mechanisms
  • Health disparities and outcomes
  • Chronic Kidney Disease and Diabetes
  • Heart Failure Treatment and Management
  • Dermatology and Skin Diseases

University of Tsukuba
2018-2025

Pharmaceuticals and Medical Devices Agency
2024-2025

London School of Hygiene & Tropical Medicine
2016-2025

University of London
2016-2025

Tsukuba International University
2023-2025

Health Services Research & Development
2019-2025

Institute for Health Metrics and Evaluation
2021-2023

University of Washington
2021-2023

Royal North Shore Hospital
2023

The University of Sydney
2023

Teklehaimanot Gereziher Haile Kaloyan Kamenov Paul Svitil Briant Aislyn U Orji Jaimie D Steinmetz and 95 more Amir Abdoli Mohammad Abdollahi Eman Abu‐Gharbieh Ashkan Afshin Haroon Ahmed Tarik A. Rashid Yonas Akalu Fares Alahdab Fahad Mashhour Alanezi Turki Alanzi Hanadi Al Hamad Liaqat Ali Vahid Alipour Rajaa Al‐Raddadi Hubert Amu Jalal Arabloo Morteza Arab‐Zozani Judie Arulappan Charlie Ashbaugh Desta Debalkie Atnafu Zaheer‐Ud‐Din Babar Atif Amin Baig Palash Chandra Banik Till Bärnighausen Amadou Barrow Rose G Bender Akshaya Srikanth Bhagavathula Nikha Bhardwaj Pankaj Bhardwaj Sadia Bibi Ali Bijani Katrin Burkart Christopher R. Cederroth Jaykaran Charan Sonali G Choudhari Dinh‐Toi Chu Rosa A S Couto Amare Belachew Dagnew Baye Dagnew Saad M A Dahlawi Xiaochen Dai Lalit Dandona Rakhi Dandona Assefa Desalew Deepak Dhamnetiya Mandira Lamichhane Dhimal Meghnath Dhimal Kerrie E Doyle Bruce Bartholow Duncan Michael Ekholuenetale Irina Filip Florian Fischer Richard C. Franklin Abhay Gaidhane Shilpa Gaidhane Silvano Gallus Farhad Ghamari Ahmad Ghashghaee Ghozali Ghozali Syed Amir Gilani Ionela-Roxana Glăvan Mahaveer Golechha Bárbara Niegia Garcia de Goulart Veer Bala Gupta Vivek Gupta Samer Hamidi Billy R. Hammond Simon I Hay Khezar Hayat Golnaz Heidari Howard J. Hoffman K Hopf Mehdi Hosseinzadeh Mowafa Househ Rabia Hussain Bing‐Fang Hwang Ivo Iavicoli Segun Emmanuel Ibitoye Olayinka Stephen Ilesanmi Seyed Sina Naghibi Irvani Sheikh Mohammed Shariful Islam Masao Iwagami Louis Jacob Sathish Kumar Jayapal Ravi Prakash Jha Jost B. Jonas Rohollah Kalhor Nawzad Kameran Al-Salihi Himal Kandel Ayele Semachew Kasa Gbenga A Kayode Rovshan Khalilov Ejaz Ahmad Khan Mahalaqua Nazli Khatib Soewarta Kosen

BackgroundHearing loss affects access to spoken language, which can affect cognition and development, negatively social wellbeing. We present updated estimates from the Global Burden of Disease (GBD) study on prevalence hearing in 2019, as well condition's associated disability.MethodsWe did systematic reviews population-representative surveys 1990 2019. fitted nested meta-regression models for severity-specific prevalence, accounting aid coverage, cause, presence tinnitus. also forecasted...

10.1016/s0140-6736(21)00516-x article EN cc-by The Lancet 2021-03-01
Min Seo Kim Jimin Hwang Dong Keon Yon Seung Won Lee Se Yong Jung and 95 more Seoyeon Park Catherine O. Johnson Benjamin Stark Christian Razo Mohammadreza Abbasian Hedayat Abbastabar Amir Parsa Abhari Victor Aboyans Denberu Eshetie Adane Adane Oladimeji Adebayo Fares Alahdab Sami Almustanyir Hany Aly Edward Kwabena Ameyaw Jason A Anderson Cătălina Liliana Andrei Zahra Aryan Avinash Aujayeb Sara Bagherieh Ovidiu Constantin Baltatu Maciej Banach Nebiyou Simegnew Bayileyegn Lindsay Bearne Amir Hossein Behnoush Isabela M. Benseñor Sonu Bhaskar Ajay Nagesh Bhat Vivek Bhat Boris Bikbov Bagas Suryo Bintoro Katrin Burkart Luis Alberto Cámera Alberico L. Catapano Eeshwar K Chandrasekar Jaykaran Charan Vijay Kumar Chattu Gerald Chi Isaac Sunday Chukwu Sheng‐Chia Chung Massimo Círillo Kaleb Coberly Vera Marisa Costa Omid Dadras Xiaochen Dai Thanh Chi Rajkumar Doshi Michael Ekholuenetale Islam Y. Elgendy Muhammed Elhadi Adeniyi Francis Fagbamigbe Alireza Feizkhah Ginenus Fekadu Paramjit Gill Mohamad Goldust Mahaveer Golechha Shi‐Yang Guan Vivek Gupta Mostafa Hadei Najah R Hadi Ahmad Hammoud Graeme J. Hankey Netanja I. Harlianto Ahmed I Hasaballah Shoaib Hassan Mohammed Bheser Hassen Golnaz Heidari Mihaela Hostiuc Olayinka Stephen Ilesanmi Masao Iwagami Mohammad Jokar Jost B. Jonas Charity Ehimwenma Joshua Jacek Jerzy Jozwiak Sina Kazemian Mohammad Keykhaei Amirmohammad Khalaji Moien AB Khan Sorour Khateri Biruk Getahun Kibret Oleksii Korzh Sindhura Lakshmi Koulmane Laxminarayana Kewal Krishan Akshay Kumar Manoj Kumar Ambily Kuttikkattu Tri Laksono Bagher Larijani Thao T. Le Stephen S Lim Xuefeng Liu Stefan Lorkowski Hassan Magdy Abd El Razek Kashish Malhotra Yosef Manla Andrea Maugeri

10.1016/s2214-109x(23)00355-8 article EN The Lancet Global Health 2023-09-19

Background To investigate the individual profile of each SGLT2 (sodium‐glucose cotransoporter‐2) inhibitor in patients with different backgrounds. Methods and Results This study included 21 placebo‐controlled randomized controlled trials a total 96 196 participants, investigating empagliflozin, ertugliflozin, dapagliflozin, canagliflozin, sotagliflozin. The primary efficacy end point was composite cardiovascular death hospitalizations for heart failure. secondary points were all‐cause death,...

10.1161/jaha.123.031805 article EN cc-by-nc-nd Journal of the American Heart Association 2024-01-31

The incidence of dry eye disease has increased; the potential for crowdsource data to help identify undiagnosed in symptomatic individuals remains unknown.To assess characteristics and risk factors associated with diagnosed using smartphone app DryEyeRhythm.A cross-sectional study crowdsourced was conducted including Japan who downloaded DryEyeRhythm completed entire questionnaire; duplicate users were excluded. released on November 2, 2016; from 2016, January 12, 2018.DryEyeRhythm collected...

10.1001/jamaophthalmol.2019.4815 article EN JAMA Ophthalmology 2019-11-27

Objectives The Ocular Surface Disease Index (OSDI) questionnaire is widely used to evaluate subjective symptoms of dry eye disease (DED) as a primary diagnostic criterion. This study aimed develop Japanese version the OSDI (J-OSDI) and assess its reliability validity. Design setting Hospital-based cross-sectional observational study. Participants A total 209 patients recruited from Department Ophthalmology at Juntendo University Hospital. Methods We translated culturally adapted into...

10.1136/bmjopen-2019-033940 article EN cc-by-nc BMJ Open 2019-11-01

Matching is a technique through which patients with and without an outcome of interest (in case-control studies) or exposure cohort are sampled from underlying to have the same similar distributions some characteristics. This used increase statistical efficiency cost studies. In studies, besides time in risk set sampling, controls often matched for each case respect important confounding factors, such as age sex, covariates large number values levels, area residence (e.g., post code)...

10.37737/ace.22005 article EN cc-by-nc-nd Annals of Clinical Epidemiology 2022-01-01

The risk and benefits of COVID-19 vaccination during pregnancy are under investigation. Pooled evidence regarding neonatal maternal outcomes in association with is scarce.

10.1001/jamapediatrics.2022.3456 article EN JAMA Pediatrics 2022-10-03

Objectives: To examine the effect of postoperative polymyxin B hemoperfusion on mortality in patients with abdominal septic shock triggered by lower gastrointestinal tract perforation, identifying subpopulations who may benefit from this treatment. Design: Propensity-matched analysis. Setting: We used a nationwide inpatient database Japan. Patients: included are 18 years old or older hospitalized during period 34 months between July 2007 and October 2011, had open surgery day admission (day...

10.1097/ccm.0000000000000150 article EN Critical Care Medicine 2013-12-23

The prevalence of dry eye disease (DED) is increasing worldwide, and its diagnosis often needs dedicated reagents machines. We investigated the usefulness maximum blink interval (MBI) (the length time that participants could keep their eyes open) in screening for DED. This cross-sectional study included 292 patients (194 with DED 98 without DED) recruited between September 2016 2017. compared MBI DED; examined correlations other clinical features DED, including subjective symptoms (Dry...

10.1038/s41598-018-31814-7 article EN cc-by Scientific Reports 2018-09-03

We assessed the survival benefit of polymyxin B hemoperfusion (PMX) in septic shock patients starting continuous renal replacement therapy (CRRT), who are known to have an increased rate mortality.Adult Japanese diagnosis procedure combination database satisfying following criteria were enrolled: hospitalized 2007-2012; diagnosed as having sepsis; required noradrenaline and/or dopamine; and started CRRT intensive care unit. Propensity scores for receiving PMX created from patient hospital...

10.1159/000444474 article EN Blood Purification 2016-01-01
Coming Soon ...